translate English to French: Lowest dermal LD50 (rabbit) = >2000 mg/kg-bw (Great Lakes Chemical Corporation, undated a) [Additional studies: / Dow Chemical Company, 1977 / Great Lakes Chemical Corporation, 1982 / 1988] Lowest dermal LD50 (rat) = >2000 mg/kg-bw (Great Lakes Chemical Corporation, 1987) [Additional studies: / Great Lakes Chemical Corporation, 1982 / 1990] Lowest dermal LD50 (rabbit) = >2000 mg/kg-bw (Great Lakes Chemical Corporation, undated b) [Additional studies: / Great Lakes Chemical Corporation, 1982; 1984] Short-term repeated-dose toxicity Lowest oral (gavage) LOEL (rat and mouse) = 18 mg/kg-bw per day: decreased thyroxine levels (2,2',4,4'-TeBDE, 98% purity, 14 days) (Hallgren and Darnerud, 1998 / 2002; Darnerud and Thuvander, 1998) [Additional studies: / Thuvander and Darnerud, 1999 / Hallgren et al., 2001]
DL50 minimale par voie cutanée (lapins) = >2 000 mg/kg p.c. (Great Lakes Chemical Corporation, sans date a) [Autres études : / Dow Chemical Company, 1977 / Great Lakes Chemical Corporation, 1982 / 1988] DL50 minimale par voie cutanée (rats) = >2 000 mg/kg p.c. (Great Lakes Chemical Corporation, 1987) [Autres études : / Great Lakes Chemical Corporation, 1982 / 1990] DL50 minimale par voie cutanée (lapins) = >2 000 mg/kg p.c. (Great Lakes Chemical Corporation, sans date b) [Autres études : / Great Lakes Chemical Corporation, 1982 / 1984] Toxicité à court terme causée par des doses répétées DMEO la plus basse par ingestion (gavage) (rats et souris) = 18 mg/kg p.c./jour : diminution des teneurs en thyroxine (2,2', 4,4'-TeBDE pur à 98 %, 14 jours) (Hallgren et Darnerud, 1998 / 2002; Darnerud et Thuvander, 1998) [Autres études : / Thuvander et Darnerud, 1999 / Hallgren et al., 2001]